Golden Seeds Cognition Therapeutics Llc - Net Worth and Insider Trading

Golden Seeds Cognition Therapeutics Llc Net Worth

The estimated net worth of Golden Seeds Cognition Therapeutics Llc is at least $1 Million dollars as of 2024-11-13. Golden Seeds Cognition Therapeutics Llc is the 10% Owner of Cognition Therapeutics Inc and owns about 2,489,691 shares of Cognition Therapeutics Inc (CGTX) stock worth over $1 Million. Details can be seen in Golden Seeds Cognition Therapeutics Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Golden Seeds Cognition Therapeutics Llc has not made any transactions after 2021-10-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Golden Seeds Cognition Therapeutics Llc

Golden Seeds Cognition Therapeutics Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Golden Seeds Cognition Therapeutics Llc owns 1 companies in total, including Cognition Therapeutics Inc (CGTX) .

Click here to see the complete history of Golden Seeds Cognition Therapeutics Llc’s form 4 insider trades.

Insider Ownership Summary of Golden Seeds Cognition Therapeutics Llc

Ticker	Comapny	Transaction Date	Type of Owner
CGTX	Cognition Therapeutics Inc	2022-09-27	10 percent owner

Golden Seeds Cognition Therapeutics Llc Latest Holdings Summary

Golden Seeds Cognition Therapeutics Llc currently owns a total of 1 stock. Golden Seeds Cognition Therapeutics Llc owns 2,489,691 shares of Cognition Therapeutics Inc (CGTX) as of October 13, 2021, with a value of $1 Million.

Latest Holdings of Golden Seeds Cognition Therapeutics Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CGTX	Cognition Therapeutics Inc	2021-10-13	2,489,691	0.60	1,489,831

Holding Weightings of Golden Seeds Cognition Therapeutics Llc

Golden Seeds Cognition Therapeutics Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Golden Seeds Cognition Therapeutics Llc has made a total of 1 transactions in Cognition Therapeutics Inc (CGTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cognition Therapeutics Inc is the sale of 33 shares on October 13, 2021, which brought Golden Seeds Cognition Therapeutics Llc around $397.

Insider Trading History of Golden Seeds Cognition Therapeutics Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Golden Seeds Cognition Therapeutics Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Golden Seeds Cognition Therapeutics Llc Ownership Network

Ownership Network List of Golden Seeds Cognition Therapeutics Llc

No Data

Ownership Network Relation of Golden Seeds Cognition Therapeutics Llc

Golden Seeds Cognition Therapeutics Llc Owned Company Details

What does Cognition Therapeutics Inc do?

Who are the key executives at Cognition Therapeutics Inc?

Golden Seeds Cognition Therapeutics Llc is the 10 percent owner of Cognition Therapeutics Inc. Other key executives at Cognition Therapeutics Inc include director & CEO & President Lisa Ricciardi , Chief Financial Officer John Brendan Doyle , and Chief Medical Officer Anthony Caggiano .

Cognition Therapeutics Inc (CGTX) Insider Trades Summary

Over the past 18 months, Golden Seeds Cognition Therapeutics Llc made no insider transaction in Cognition Therapeutics Inc (CGTX). Other recent insider transactions involving Cognition Therapeutics Inc (CGTX) include a net purchase of 5,700 shares made by Lisa Ricciardi ,

In summary, during the past 3 months, insiders sold 0 shares of Cognition Therapeutics Inc (CGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cognition Therapeutics Inc (CGTX) were sold and 5,700 shares were bought by its insiders, resulting in a net purchase of 5,700 shares.

Cognition Therapeutics Inc (CGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cognition Therapeutics Inc Insider Transactions

No Available Data

Golden Seeds Cognition Therapeutics Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Golden Seeds Cognition Therapeutics Llc. You might contact Golden Seeds Cognition Therapeutics Llc via mailing address: C/o Golden Seeds, Box541473, Flushing Ny 11354.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.